Overview

Update
Total Equity Funding
Undisclosed Amount in 2 Rounds from 5 Investors
Most Recent Funding
Series A on January 29, 2015 / Undisclosed Amount
Headquarters:
Jena, Thuringen
Description:
oncgnostics develops IVD tests for screening, therapeutic decision making, and follow-up care in cancer diagnostics.
Founders:
, , ,
Categories:
Biotechnology, Health Diagnostics
Website:
http://www.oncgnostics.com

Company Details

Update

oncgnostics develops - based on proprietary epigenetic biomarkers - highly reliable in vitro diagnostic (=IVD) tests for screening, therapeutic decisions and follow-up care in cancer diagnostics.

The diagnostic tests developed by oncgnostics are based on DNA regions specifically methylated in precancerous and carcinoma cells. These marker regions are detected using well-established PCR-based technologies, which can be performed in routine molecular diagnostics laboratories with standard equipment. oncgnostics has identified novel markers for detecting cervical precancerous lesions and carcinomas.

Funding Rounds (2) - undisclosed

Update
DateAmount / RoundValuationLead InvestorInvestors
Jan, 2015undisclosed amount / Series A5
Apr, 2012undisclosed amount / Seed2

Current Team (4)

Update

News (1)

Update
DateNews
Apr 17, 2012FinSMEs - FinSMEs

Competitors (1)

Update
  • Along with Roche Pharmaceuticals, Roche Diagnostics is an important part of the foundation that modern healthcare builds upon.

Offices/Locations (1)

Update
  • Office

    BioInstrumentezentrum Jena

    Winzelaer Str. 2

    Jena, Thuringen 07745

    Germany

Images (1)

Update

Add Acquisitions

Add Board Members and Advisors

Add Products

Add Sub Organizations

Add Memberships

Add Customers

Add Partners

Add Videos